Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $2.82, but opened at $3.04. Curaleaf shares last traded at $2.99, with a volume of 114,002 shares.
Analysts Set New Price Targets
Separately, Cormark upgraded shares of Curaleaf from a “hold” rating to a “moderate buy” rating in a report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Strong Buy”.
View Our Latest Report on CURLF
Curaleaf Stock Down 1.2%
Curaleaf (OTCMKTS:CURLF – Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. As a group, research analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.
Curaleaf Company Profile
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
See Also
- Five stocks we like better than Curaleaf
- Industrial Products Stocks Investing
- As the Market Rotates, This Healthcare ETF Is Leading the Way
- What is the Australian Securities Exchange (ASX)
- These 3 Chinese Stocks Could Be a Ticking Time Bomb of Growth
- Options Trading – Understanding Strike Price
- 3 Industrial Giants Positioned for Defense-Led Growth
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.